The manufacturers of flu vaccines for the 2015-2016 season are GlaxoSmithKline, ID Biomedical Corporation of Quebec, Sanofi Pasteur, bioCSL, and Novartis Vaccines and Diagnostics, according to the U.S. Food and Drug Administration. Protein Sciences and MedImmune produce flu vaccines as well. Manufacturers make a trivalent formulation of the vaccine, which contains two Type A virus strains and one Type B, and the quadrivalent form, which consists of the three strains and an additional Type B virus.
GlaxoSmithKline, ID Biomedical Corporation of Quebec and Sanofi Pasteur manufacture the quadrivalent form of the influenza vaccine, states the U.S. Centers for Disease Control and Prevention. GlaxoSmithKline makes Fluarix Quadrivalent. ID Biomedical Corporation of Quebec manufactures FluLaval Quadrivalent, but GlaxoSmithKline distributes the product for the company. Sanofi Pasteur produces Fluzone Quadrivalent. Fluarix, FluLaval and Fluzone are available as standard-dosage injections. MedImmune makes FluMist Quadrivalent, which is a nasal spray.
BioCSL, Novartis Vaccines and Diagnostics, Sanofi Pasteur and Protein Sciences make the trivalent form of the influenza vaccines, notes the CDC. BioCSL manufactures Afluria, and Novartis Vaccines and Diagnostics produces Fluvirin and FluceIvax. Sanofi Pasteur makes Fluzone and Fluzone High-Dose, and Protein Sciences manufactures FluBlok. Afluria, Fluvirin and FluceIvax are standard-dosage injections. Fluzone is available as a standard- or high-dosage injection.